| J0897 | Injection, denosumab, 1 mg | 7,200 | $20 | $129.6K |
| Q5111 | Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 790 | $110 | $86.4K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 370 | $150 | $54.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 420 | $100 | $43K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 380 | $110 | $42.8K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 40,500 | $1 | $40.5K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 5,780 | $10 | $34.7K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 3,200 | $10 | $19.2K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 150 | $100 | $14.7K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 550 | $30 | $13.8K |